TIME TO MARKET ACCESS FOR INNOVATIVE DRUGS IN THE UK, FRANCE, AND BELGIUM

被引：0

作者：

Maervoet, J. ^{[1
]}

Toumi, M. ^{[2
]}

机构：

[1] Deloitte, Diegem, Belgium

[2] Univ Lyon 1, F-69365 Lyon, France

来源：

VALUE IN HEALTH | 2012年 / 15卷 / 07期

关键词：

D O I：

10.1016/j.jval.2012.08.674

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A312 / A312

页数：1

共 50 条

[31] MEDICAL ACCESS STRATEGY TO IMPROVE ACCESS TO INNOVATIVE AND EXPENSIVE THERAPY IN FRANCE
Cohen, S.
Paubel, P.
Monchecourt, F.
VALUE IN HEALTH, 2018, 21 : S92 - S92
[32] PROJECT ORBIS & THE UK: 18-MONTH REPORT CARD - IMPLICATIONS OF UK MARKET ACCESS FOR ONCOLOGY DRUGS PRIOR TO EUROPE
Macaulay, R.
VALUE IN HEALTH, 2022, 25 (12) : S236 - S236
[33] EARLY ACCESS IN FRANCE: REASONS FOR REFUSALS AND IMPACT ON MARKET ACCESS
Theuillon, T.
Villemur, L.
Le Mao, J.
VALUE IN HEALTH, 2023, 26 (12) : S347 - S347
[34] MARKET ACCESS IMPLICATIONS OF EARLY ACCESS TO MEDICINES SCHEME IN THE UK
Jaiswal, H.
Blake, L.
D'Ausilio, A.
Parkinson, M.
VALUE IN HEALTH, 2023, 26 (12) : S287 - S288
[35] BIOSIMILARS: MARKET ACCESS AND MARKET PENETRATION - A COMPARISON OF FRANCE AND GERMANY
Freiberg, M.
Schwarz, R.
Khoury, C.
VALUE IN HEALTH, 2016, 19 (07) : A442 - A442
[36] EARLY ACCESS IN FRANCE: REASONS FOR REFUSALS AND IMPACT ON MARKET ACCESS
Theuillon, T.
Villemur, L.
VALUE IN HEALTH, 2022, 25 (12) : S279 - S279
[37] TIME FOR REIMBURSEMENT AND PRICING FOR DRUGS DEPENDING ON THE EARLY ACCESS STATUS IN FRANCE (WITH OR WITHOUT ATU)
Le Tohic, D.
Benazet, F.
Gurnot, S.
Andriany, T.
Berard, I
VALUE IN HEALTH, 2019, 22 : S799 - S800
[38] SQUARING THE CIRCLE: INNOVATIVE CONTRACTING TO ACHIEVE MARKET ACCESS FOR INNOVATIVE PRODUCTS
Street-Docherty, L. M.
Morrison, S.
VALUE IN HEALTH, 2013, 16 (07) : A488 - A488
[39] MARKET ACCESS OF ATMPS IN FRANCE: CHALLENGES AND OPPORTUNITIES
Le Mao, J.
Parant, P.
Villemur, L.
VALUE IN HEALTH, 2023, 26 (12) : S389 - S389
[40] INNOVATION STRATEGIES IN THE FLOW MEASURING INDUSTRY - THE CASES OF THE UK, FRANCE AND BELGIUM
SMITH, HL
FLOW MEASUREMENT AND INSTRUMENTATION, 1994, 5 (01) : 23 - 30

← 1 2 3 4 5 →